Kristen Carroll, MD
Article
Improving HF Outcomes in Obesity and Type 2 Diabetes: The Role of Semaglutide
December 2, 2024
Clinical question: Does semaglutide improve heart failure (HF) symptoms in patients with obesity-related HF and type 2 diabetes? Background: Obesity-related HF and type 2 diabetes are prevalent...
Gastrointestinal Risks Associated with GLP-1 Receptor Agonists in Patients with Obesity
December 2, 2024
Clinical question: What is the risk of gastrointestinal adverse events associated with glucagon-like peptide-1 (GLP-1) receptor agonists used for weight loss compared to...